− Late-breaking data presented from a Phase 2a trial at UEG Week 2019, Barcelona, Spain, highlights potential of investigational medicine to prevent gluten induced immune activation in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback